Benjamin C. Yaden - Concepedia

Author

Benjamin C. Yaden

Eli Lilly (United States)

Also Known As

B C Yaden, B. C. Yaden, B.C. Yaden, Benjamin C Yaden, Benjamin C. Yaden, Benjamin Yaden, Benjamin C. Yaden

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)Indiana University – Purdue University Indianapolis Foundation for Applied Molecular Evolution University of Houston Karolinska Institutet

About

Benjamin C. Yaden is an author at Eli Lilly (United States) specializing in medicine, physiology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	586
2	Health Sciences	2	2	81
3	Engineering	1	1	39
4	Natural Sciences	1	1	19
5	Public Health	1	1	22

Benjamin C. Yaden

Publications

917

Citations

H-Index

Page 1

	Year	Citations
ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis Feng He, Peng Zhang, Junlai Liu, Journal of Hepatology HepatologyLiver PhysiologyPathologyStress-related FerroptosisLiver Cancer	2023	330
The Hypolipidemic Natural Product Guggulsterone Is a Promiscuous Steroid Receptor Ligand Thomas P. Burris, Chahrzad Montrose, Keith A. Houck, Molecular Pharmacology	2004	130
Involvement of estrogen receptor β in maintenance of serotonergic neurons of the dorsal raphe Hitoshi Suzuki, Rodrigo P. A. Barros, Nobuhiro Sugiyama, Molecular Psychiatry Dorsal RapheEstrogen Receptor βMolecular NeuroscienceHormonal ReceptorPhysiology	2012	76
Follistatin: A Novel Therapeutic for the Improvement of Muscle Regeneration Benjamin C. Yaden, Johnny E. Croy, Yan Wang, Journal of Pharmacology and Experimental Therapeutics	2014	61
Reduction of dendritic spines and elevation of GABAergic signaling in the brains of mice treated with an estrogen receptor β ligand Xin-jie Tan, Yu-bing Dai, Wan-fu Wu, Proceedings of the National Academy of Sciences	2012	49
Human Splicing Factor SPF45 (<i>RBM17</i>) Confers Broad Multidrug Resistance to Anticancer Drugs When Overexpressed— a Phenotype Partially Reversed By Selective Estrogen Receptor Modulators William L. Perry, Robert L. Shepard, Janardhan Sampath, Cancer Research Spf45-mediated Drug ResistancePharmacotherapyCancer BiologyTumor BiologyDrug Resistance	2005	41
Molecular Targets of Androgen Signaling that Characterize Skeletal Muscle Recovery and Regeneration James G. MacKrell, Benjamin C. Yaden, Heather A. Bullock, Nuclear Receptor Signaling Muscle FunctionMolecular TargetsSkeletal Muscle MassGlucocorticoid ReceptorCellular Physiology	2015	40
Inhibition of Activin A Ameliorates Skeletal Muscle Injury and Rescues Contractile Properties by Inducing Efficient Remodeling in Female Mice Benjamin C. Yaden, Yan X. Wang, Jonathan M. Wilson, American Journal Of Pathology Regenerative MedicineMechanobiologySoft Tissue InjuryMuscle FunctionDevelopmental Biology	2014	39
An Engineered Human Follistatin Variant: Insights into the Pharmacokinetic and Pharmocodynamic Relationships of a Novel Molecule with Broad Therapeutic Potential Amita Datta‐Mannan, Benjamin C. Yaden, Venkatesh Krishnan, Journal of Pharmacology and Experimental Therapeutics	2012	28
Development of a selective androgen receptor modulator for transdermal use in hypogonadal patients Venkatesh Krishnan, Nita Patel, James G. MacKrell, Andrology Hormonal ContraceptiveFertilitySkin Absorption PropertiesReproductive HealthGynecology	2018	22

Page 1